Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
AND019 / Hangzhou Andao Pharma
NCT05187832: A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer	Recruiting	1	61	US	AND019 PO QD	Kind Pharmaceuticals LLC	Advanced or Metastatic Breast Cancer	05/26	05/26